Genus (STU:GBE) EBIT per Share : €1.02 (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Genus EBIT per Share?

Genus's EBIT per Share for the six months ended in Dec. 2023 was €0.44. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €1.02.

During the past 12 months, the average EBIT per Share Growth Rate of Genus was 19.30% per year. During the past 3 years, the average EBIT per Share Growth Rate was -10.90% per year. During the past 5 years, the average EBIT per Share Growth Rate was 21.30% per year. During the past 10 years, the average EBIT per Share Growth Rate was 2.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Genus's EBIT per Share or its related term are showing as below:

STU:GBE' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -40 Med: 8.7 Max: 126.8
Current: -10.9

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Genus was 126.80% per year. The lowest was -40.00% per year. And the median was 8.70% per year.

STU:GBE's 3-Year EBIT Growth Rate is ranked worse than
66.97% of 1305 companies
in the Biotechnology industry
Industry Median: 3.6 vs STU:GBE: -10.90

Genus's EBIT for the six months ended in Dec. 2023 was €28.8 Mil.

Genus EBIT per Share Historical Data

The historical data trend for Genus's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genus EBIT per Share Chart

Genus Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

EBIT per Share

Get a 7-Day Free Trial

0.24

0.87

1.07

0.96

0.95

Genus Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT per Share	Get a 7-Day Free Trial															0.48	0.49	0.36	0.59	0.44

Genus EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Genus's EBIT per Share for the fiscal year that ended in Jun. 2023 is calculated as

	EBIT per Share		(A: Jun. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	62.582	/	65.988
=	0.95

Genus's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	28.787	/	66.220
=	0.43

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €1.02

Genus (STU:GBE) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Genus EBIT per Share Related Terms

Thank you for viewing the detailed overview of Genus's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Genus (STU:GBE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genus PLC (STU:GBE) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

GENSF:USA GNSl:UK GNS:UK GBE:Germany

Address

Matrix House, Basing View, Basingstoke, Hants, GBR, RG21 4DZ

Website

https://www.genusplc.com

Genus PLC is a biotechnology company that develops animal genetics for agricultural purposes. The company breeds and distributes the genes of pigs and bulls, scientifically selecting livestock whose offspring are designed to increase the profitability of its customers. In the porcine market, Genus sells boars and sows that produce offspring with desirable characteristics, such as feed-efficient growth or leaner meat. In the dairy and beef markets, the company's primary product is bull semen, which is delivered through artificial insemination to improve its customers' herds and their efficiency. Genus also offers embryos through its subsidiary IVB.

Genus (STU:GBE) Headlines

No Headlines